New treatments like phage therapy are being used to fight the deadly risk of antibiotic resistance, and Resistell is working to speed up and improve the identification of bacteria and the prescription of the correct medicines.
The Access To Medicine foundation warns that antibiotic supply chain issues are helping to fuel the rise in AMR Their solution? ‘The right products need to reach the right patients at the right time’ - exactly what Resistell is working toward.
Discover how the search for a rapid diagnostic system lies at the heart of tackling antibiotic resistance, a problem which is predicted to kill 10 million people a year by 2050. Resistell is working to create the innovative solutions needed
The Centers for Disease Control and Prevention (CDC) have outlined the ways in which health departments can prevent the spread of antibiotic resistance. Rapid identification of resistant bacteria is at the heart of their strategy. Resistell is helping to make that a reality.
Bacteria such as Pseudomonas aeruginosa are becoming resistant to the widely used antibiotic Ciprofloxacin (CIP). As resistance like this spreads the pioneering work of Resistell becomes more urgent. See how we’re leading the search for faster and more accurate diagnosis.
The World Health Organisation warns that antibiotic resistance could lead to cuts and minor surgery causing fatal infections and cancer treatments becoming increasingly difficult. See how Resistell is working toward faster and more accurate diagnosis and treatment.
First case of super-resistant gonorrhea reported⚠️ The emergence of a strain of ‘super-gonorrhoea’, resistant to existing antibiotics, means that a global medical crisis is closer to becoming a reality. @Resistell are utilising the latest technology to create the speed and accuracy needed to fight back against that crisis.
Real world testing of Resistell methods is the next step in refining and making actual use of our innovations. Our device produces the resistance profile of a pathogen within a few hours instead of days.
We are glad to inform all of you that the new poster with a Winner of the first Swissbiolabs Start-up Challenge is placed in front of the FHNW in Olten (Switzerland) !
It is estimated that at least 700 000 people die every year from the infections caused by antibiotic resistant bacteria. If no action is taken the death toll may reach 10 million a year by 2050. It is more than the number of people currently dying from road traffic accidents and cancer together.
Pictures of the Swiss Diagnostics Start-Up Day 2017! 90 participants, six startup pitches, two keynotes, five supporting organisations, an inspiring success story and a proud winner of 5’000 CHF were impressive facts of the first Swiss Diagnostics Start-up Day in Olten!
